This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Calcium with ergocalciferol oral


Oral formulations of calcium with ergocalciferol.

Drugs List

  • calcium with ergocalciferol tablets
  • Therapeutic Indications


    Treatment of calcium and vitamin D deficiency



    Calcium and vitamin D deficiency
    One tablet daily.
    Severe calcium and vitamin D deficiency
    As directed by physician.


    The manufacturer recommends to use as directed by a physician.

    Other sources suggest that calcium and ergocalciferol tablets are not licensed for use in children under 6 years of age.


    Hypervitaminosis D
    Hereditary fructose intolerance
    Metastatic calcification
    Prolonged immobilisation with hypercalciuria and/or hypercalcaemia
    Severe hypercalcaemia
    Severe hypercalciuria
    Severe renal impairment
    Skeletal metastasis

    Precautions and Warnings

    Children under 6 years
    Predisposition to nephrolithiasis
    Electrolyte imbalance
    Glucose-galactose malabsorption syndrome
    History of nephrolithiasis
    Lactose intolerance
    Malabsorption associated with chronic gastrointestinal disorders
    Mild renal impairment

    Allow for calcium and vitamin D intake from other sources
    Contains lactose
    Preparation contains sucrose
    Breastfeeding: Hypercalcaemia of infant possible if mother taking vitamin D
    Check serum calcium level if nausea and vomiting occur
    Monitor renal function on long term therapy
    Monitor serum and urinary calcium in patients with sarcoidosis
    Monitor serum calcium levels in patients with renal impairment
    Monitor serum calcium levels on prolonged use
    Reduce dose/temporarily withdraw treatment if hypercalcaemia occurs
    Discontinue or reduce dose if renal impairment worsens

    Pregnancy and Lactation


    Use calcium with ergocalciferol with caution during pregnancy.

    The manufacturer recommends that the use of calcium and ergocalciferol during pregnancy should only be under the direction of a physician and should only be used during the second and third trimester of pregnancy.


    Use calcium with ergocalciferol with caution during breastfeeding.

    Vitamin D and its metabolites pass in to breast milk. This should be taken into consideration when giving additional vitamin D to a child.

    Breast milk from women taking pharmacological doses of vitamin D may cause hypercalcaemia if given to an infant. Serum calcium concentrations should be monitored in the breastfeeding neonate.

    Low dose vitamin D (up to 10micrograms/400IU per day) can be taken by breastfeeding women. It helps ensure that the mother's requirements for vitamin D are met but also builds up adequate foetal stores for early infancy (Specialist Pharmacy Service).

    Side Effects

    Decreased appetite
    Dry mouth


    It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

    The following number will direct the caller to the relevant local centre (0844) 892 0111

    Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( ) or if this is unavailable at the backup site ( ).

    Further Information

    Last Full Review Date: July 2019

    Reference Sources

    Summary of Product Characteristics: Calcium and Ergocalciferol tablets. Crescent Pharma Limited. September 2016.

    NICE Evidence Services Available at: Last accessed: 5 July 2019

    Specialist Pharmacy Service (SPS)
    Available at:
    Safety in Lactation: Vitamins. Last revised: 19 April 2016
    Last accessed: 5 July 2019

    Access the full UK drug database with a FREE Medscape UK Account
    It takes just a few minutes, and you’ll get unlimited access to information on over 11,000 UK drugs.
    Register for Free

    Already a member? Log in

    Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content

    FDB Logo

    FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.